Skip to main content

Table 3 Clinical evolution

From: Effects on muscle performance of NSAID treatment with Piroxicam versus placebo in geriatric patients with acute infection-induced inflammation. a double blind randomized controlled trial

   Placebo Piroxicam p
Clinical evolution (number of patients)     
  Return to premorbid
clinical status
6 10 0.127*
  Persistent decrease in
clinical status
8 4  
Side effects (attributable to NSAID)     
  None 13 8 0.075*
  Possible 1 3  
  Probable 0 3  
Length of stay (days; median, range)   24.5 (19-64) 29.0 (9-75) 0.836
Death   1 2 0.541*
  1. *Pearson Chi square test. Mann Whitney U test.